10X GENOMICS INC's ticker is TXG and the CUSIP is 88025U109. A total of 254 filers reported holding 10X GENOMICS INC in Q3 2023. The put-call ratio across all filers is 0.48 and the average weighting 0.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,810,819 | -29.3% | 43,876 | -4.3% | 0.00% | -25.0% |
| Q2 2023 | $2,560,200 | +16.8% | 45,849 | +16.7% | 0.00% | 0.0% |
| Q1 2023 | $2,191,052 | +163.6% | 39,280 | +72.3% | 0.00% | +100.0% |
| Q4 2022 | $831,318 | +78.8% | 22,802 | +39.8% | 0.00% | +100.0% |
| Q3 2022 | $465,000 | -64.8% | 16,308 | -46.6% | 0.00% | -66.7% |
| Q2 2022 | $1,321,000 | -40.0% | 30,529 | +5.5% | 0.00% | -25.0% |
| Q1 2022 | $2,202,000 | -29.0% | 28,948 | +39.1% | 0.00% | -33.3% |
| Q4 2021 | $3,100,000 | -9.9% | 20,812 | -11.9% | 0.01% | -14.3% |
| Q3 2021 | $3,439,000 | -25.8% | 23,626 | -0.1% | 0.01% | -30.0% |
| Q2 2021 | $4,633,000 | +16.5% | 23,659 | +7.7% | 0.01% | 0.0% |
| Q1 2021 | $3,976,000 | +865.0% | 21,967 | +654.4% | 0.01% | +900.0% |
| Q4 2020 | $412,000 | – | 2,912 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Venrock Management VI, LLC | 962,309 | $188,439,000 | 95.08% |
| Foresite Capital Management II, LLC | 1,753,528 | $343,376,000 | 92.37% |
| Foresite Capital Management I, LLC | 750,000 | $146,865,000 | 88.53% |
| 12 West Capital Management LP | 1,922,000 | $376,366,000 | 15.78% |
| Financial Consulate Inc. | 141,258 | $27,661,000 | 9.97% |
| FINANCIAL CONSULATE, INC | 141,258 | $27,661,000 | 9.97% |
| Meritech Capital Associates V L.L.C. | 1,793,871 | $351,276,000 | 7.51% |
| Andar Capital Management HK Ltd | 51,000 | $9,987,000 | 6.81% |
| JS Capital Management LLC | 540,589 | $105,858,000 | 5.12% |
| Renaissance Capital LLC | 97,281 | $19,050,000 | 3.01% |